Current studies

The studies listed below are being conducted at Newcastle University, with links to NCMD. They are ongoing and from time to time need people to take part in them. Where this is the case, there is a link showing how you can get involved.

Guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment resistant depression (BRIGhTMIND)

The BRIGhTMIND study is looking at the effectiveness of a new approach to treat treatment resistant depression (TRD) using pulses of magnetic stimulation applied to the scalp.

Read more
Psilocybin Study

The Psilocybin Study is a multi-centred worldwide clinical trial examining the safety and efficacy of psilocybin (the ‘magic’ in ‘magic mushrooms’) in participants with treatment resistant depression.

Read more
Randomised placebo controlled trial of Pramipexole in addition to mood stabilisers for treatment resistant bipolar depression (PAX-BD)

Excerpt- PAX-BD is a major trial investigating the effectiveness and safety of a drug, pramipexole, which is currently used to treat Parkinson’s Disease, for patients with treatment resistant bipolar depression.

Read more
Lithium versus Quetiapine in Depression (LQD)

The LQD study is investigating which of two medications (lithium or quetiapine) added to an antidepressant is best in helping people with treatment resistant depression.

Read more
Optimizing response to lithium treatment through personalised and multimodal evaluation of individuals with bipolar I disorder (the R-LiNK study)

R-LiNK is an EU-funded, multicentre longitudinal observational study that aims to determine which individuals with bipolar I disorder are most eligible for long-term lithium treatment in terms of response, safety and tolerability.

Read more
Collaboratively Augmenting Longitudinal Monitoring (CALM)

Clinicians have worked collaboratively with young people and their families to develop an App for mood monitoring for young people aged 15-25 years with Early Onset Bipolar Disorder.

Read more
Exploring the Cause and Prevalence of Memory Problems in Mental Health (CAPMEM)

The CAPMEM study is exploring whether the autonomic nervous system works differently in people with mental health, neurodevelopmental, and neurodegenerative disorders and whether this explains the memory and concentration problems in these populations.

Read more
Adaptive Life Functioning Inventory Study (ALFI)

The ALFI study is examining the psychometric properties of a newly developed questionnaire (“ALFI”) in a sample of typically developing young people aged 16-25 years, to more accurately measure adaptive functioning in this population.

Read more
Effectiveness and efficiency of VNS Therapy as adjunctive therapy in patients with difficult to treat depression (RESTORE-LIFE)

The RESTORE-LIFE study looking at the effectiveness and efficiency of Vagus Nerve Stimulation (VNS) in difficult to treat patients with depression.

Read more
Surveillance of Incidence of first time diagnosis of Early Onset Depression in children aged 3-13 years in the UK and ROI (EOD-UK & ROI)

The EOD-UK & ROI study is investigating the incidence of first time diagnosis, management, clinical presentations, and outcome for children diagnosed with Early Onset Depression.

Read more
Evaluation of Parent Intervention for Challenging Behaviour in Children with Intellectual Disabilities (EPICC-ID)

EPICC-ID is a trial evaluating the clinical and cost effectiveness of a parenting group, Level 4 Stepping Stones Triple P (SSTP), designed to reduce challenging behaviour in preschool children with a moderate to severe intellectual disability.

Read more